Asuragen said last week that it will develop and manufacture RNA control kits for Affymetrix.
The control kits are intended for use with Asuragen-made in vitro transcription reagent kits for clinical molecular diagnostic applications that run on the Affy platform.
Austin, Tex.-based Asuragen said the kits will be configured for use with the GeneChip System 3000Dx version 2, and will be made available to companies developing and commercializing tests on the GeneChip platform. There are currently more than 20 different molecular assay tests based on the Affy platform under development by Affy and 11 partners, Asuragen said.
Asuragen inked a deal to manufacture in vitro transcription reagent kits for use with Affy's diagnostic microarray platform in July 2008 (see BAN 7/8/2008). The companies have also cooperated on other products. Asuragen began offering DiscovArray, an Affy-manufactured chip for microRNA expression profiling, in 2007 (see BAN 8/7/2007).
Financial details of the new agreement were not discussed.